A carregar...

Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells

Immunotherapy of brain tumors is rapidly emerging as a potential clinical option [1–3]. The quality and magnitude of immune responses evoked by the new generation anti-tumor vaccines is in general highly dependent on the source or choice of peptide antigens, and as well, a suitable immunopotentiator...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hofman, F.M., Stathopoulos, A., Kruse, C.A., Chen, T. C., Schijns, V.E.J.C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3999913/
https://ncbi.nlm.nih.gov/pubmed/20879986
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!